Showing results (101-110 of 252) with videos related to

Sort By:
Pageof 26
Rheumatology International|October 5, 2017
Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysisLi-Na Liu, Peng Wang, Shi-Yang Guan, et al.
Expert Opinion on Therapeutic Targets|April 14, 2017
Competitive endogenous RNA network: potential implication for systemic lupus erythematosusLian-Ju Li, Wei Zhao, Sha-Sha Tao, et al.
Current Pharmaceutical Design|September 3, 2019
TREX1 As a Potential Therapeutic Target for Autoimmune and Inflammatory DiseasesSha-Sha Tao, Guo-Cui Wu, Qin Zhang, et al.
Postgraduate Medicine|September 27, 2016
Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysisPeng Wang, Tian-Tian Lv, Shi-Yang Guan, et al.
BMC Veterinary Research|October 14, 2016
Pathological and immunological characteristics of piglets infected experimentally with a HP-PRRSV TJ strainZhenguang Li, Yanliang He, Xiaoqin Xu, et al.
International Immunopharmacology|May 20, 2026
Rb1 exerts anti-inflammatory effects and suppresses BoHV-1 replication by activating Caspase-3 and regulating the NF-κB signaling pathwayYiming Wei, Xiaolin Wang, Keyan Li, et al.
Annals of Translational Medicine|January 6, 2022
Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkersHang Yin, Xiaoyuan Wang, Nannan Jin, et al.
Molecular Immunology|January 20, 2022
Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosusJun Wu, Li-Jun Deng, Yuan-Rui Xia, et al.
Inflammation|October 4, 2016
Interleukin-35: a Potential Therapeutic Agent for Autoimmune DiseasesShi-Yang Guan, Rui-Xue Leng, Muhammad Imran Khan, et al.
Optics Express|June 6, 2013
Fano resonance of nanoparticles embedded in Fabry-Perot cavitiesJianhong Zhou, Xiping Xu, Wenbo Han, et al.
Pageof 26